Natural Polysaccharides and the Microbiota-Gut-Brain Axis

In a study published in Carbohydrate Polymers, researchers present a comprehensive review of how natural polysaccharides could modulate the microbiota-gut-brain axis (MGBA) and potentially influence pathways related to depression. The review suggests that depression is a systemic disorder involving MGBA dysfunction, rather than merely a central nervous system issue. This perspective opens new avenues for understanding and potentially addressing depressive symptoms through dietary components like natural polysaccharides.

The Role of the Microbiota-Gut-Brain Axis

The MGBA is a complex communication network that links the gut microbiota with the brain. It plays a significant role in maintaining mental health and is increasingly being implicated in the pathogenesis of depression. According to the review, factors such as gut microbial dysbiosis, barrier disruption, immune inflammation, metabolic disturbances, oxidative stress, mitochondrial injury, and impaired neuroplasticity collectively contribute to depressive pathology.

Natural polysaccharides, which are complex carbohydrates found in various foods, are highlighted as potential modulators of the MGBA. These compounds are not only defined by their source or sugar content but also by their monosaccharide composition, glycosidic linkages, branching architecture, and molecular-weight distribution. These structural features influence how polysaccharides interact with the gut microbiota and, consequently, how they might affect the MGBA.

Mechanisms of Action

The review outlines several mechanisms through which natural polysaccharides may exert their effects on the MGBA. These include rebuilding gut microbial ecology, reprogramming the metabolism of short-chain fatty acids, tryptophan-derived indoles, and bile acids, and restoring the integrity of the intestinal and blood-brain barriers. Additionally, polysaccharides may suppress neuroimmune activation and oxidative injury, support mitochondrial homeostasis, and promote neurogenesis and synaptic plasticity through the BDNF-TrkB pathway.

These actions suggest that polysaccharides could potentially alleviate depression-related abnormalities by targeting multiple pathways within the MGBA. However, the review emphasizes that the effects of polysaccharides are highly dependent on their structural characteristics, which determine their microbial accessibility, fermentation kinetics, and metabolite output.

Challenges and Limitations

While the review presents a promising perspective on the use of natural polysaccharides, it also acknowledges several challenges and limitations. One significant challenge is the attribution of specific activities to particular polysaccharides, given the complexity of their structures and interactions. Quality control, pharmacokinetics, and the variability of microbiome-dependent responses also pose hurdles for translating these findings into practical applications.

Furthermore, the review highlights the need for stratified, mechanism-guided approaches to effectively utilize polysaccharides as adjunctive tools in modulating the MGBA. This requires a deeper understanding of how individual variations in microbiome composition can influence the response to polysaccharides.

For readers interested in the broader implications of gut health, our introduction to the microbiome offers foundational insights into this complex and dynamic system.